Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group
Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. // Pancreatology. – URL: https://www.sciencedirect.com/science/article/pii/S1424390326008793?dgcid=rss_sd_all
Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Pancreatology. https://www.sciencedirect.com/science/article/pii/S1424390326008793?dgcid=rss_sd_all
“Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group.” Pancreatology.
@article{article61684,
title = {Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group},
journal = {Pancreatology},
url = {https://www.sciencedirect.com/science/article/pii/S1424390326008793?dgcid=rss_sd_all}
}